Audentes Therapeutics, Inc. (BOLD) financial statements (2022 and earlier)

Company profile

Business Address 600 CALIFORNIA ST., 17TH FLOOR
SAN FRANCISCO, CA 94108
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments351,464378,638369,504414,307280,686314,434326,128
Cash and cash equivalents63,59098,995133,160144,349104,339214,495230,864
Short-term investments287,874279,643236,344269,958176,34799,93995,264
Restricted cash and investments      90
Other undisclosed current assets4,91914,2033,6515,4654,6424,9973,155
Total current assets:356,383392,841373,155419,772285,328319,431329,373
Noncurrent Assets
Operating lease, right-of-use asset24,85925,577 
Property, plant and equipment38,16537,46734,73132,09930,65329,34026,436
Long-term investments and receivables  5,517 1,252  
Long-term investments  5,517 1,252  
Intangible assets, net (including goodwill)11,63111,63111,63111,63111,63111,63111,631
Goodwill3,6313,6313,6313,6313,6313,6313,631
Intangible assets, net (excluding goodwill)8,0008,0008,0008,0008,0008,0008,000
Restricted cash and investments3,7483,7483,7483,7483,6043,6043,604
Other noncurrent assets6,7226,8505,3055,3055,3052,0452,045
Other undisclosed noncurrent assets  21,089    
Total noncurrent assets:85,12585,27382,02152,78352,44546,62043,716
TOTAL ASSETS:441,508478,114455,176472,555337,773366,051373,089
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities24,45524,07823,33121,05118,80416,34313,350
Accounts payable9,9057,18111,8118,1233,2244,9595,301
Accrued liabilities14,55016,89711,52012,92815,58011,3848,049
Debt3,3993,247     
Deferred rent credit   456442424 
Business combination, contingent consideration, liability   2,345  2,359
Deferred revenue and credits410
Other undisclosed current liabilities  2,773    
Total current liabilities:27,85427,32526,10423,85219,24616,76716,119
Noncurrent Liabilities
Long-term debt and lease obligation26,49027,444     
Operating lease, liability26,49027,444 
Liabilities, other than long-term debt3,7053,6432,5445,9497,9208,2654,468
Deferred revenue and credits2,694
Deferred rent credit   4,7204,0784,182 
Asset retirement obligations231226221215512769760
Deferred tax liabilities, net1,0141,0141,0141,014
Deferred income tax liabilities1,0141,014 
Business combination, contingent consideration, liability2,4602,4032,323 2,3162,300 
Other undisclosed noncurrent liabilities  24,533 525560
Total noncurrent liabilities:30,19531,08727,0775,9497,9728,3204,528
Total liabilities:58,04958,41253,18129,80127,21825,08720,647
Stockholders' equity
Stockholders' equity attributable to parent383,459419,702401,995442,754310,555340,964352,442
Additional paid in capital842,599833,101770,789762,284594,480588,594568,756
Accumulated other comprehensive income (loss)22622667(60)(47)(43)(94)
Accumulated deficit(459,366)(413,625)(368,861)(319,470)(283,878)(247,587)(216,220)
Total stockholders' equity:383,459419,702401,995442,754310,555340,964352,442
TOTAL LIABILITIES AND EQUITY:441,508478,114455,176472,555337,773366,051373,089

Income statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Operating expenses(47,825)(47,077)(51,830)(37,598)(37,735)(32,629)(26,410)
Operating loss:(47,825)(47,077)(51,830)(37,598)(37,735)(32,629)(26,410)
Nonoperating income2,0842,3132,4392,0061,4441,262839
Investment income, nonoperating2,1122,3532,4722,3681,5091,294859
Other nonoperating expense(28)(40)(33)(362)(65)(32)(20)
Net loss available to common stockholders, diluted:(45,741)(44,764)(49,391)(35,592)(36,291)(31,367)(25,571)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net loss:(45,741)(44,764)(49,391)(35,592)(36,291)(31,367)(25,571)
Comprehensive loss:(45,741)(44,764)(49,391)(35,592)(36,291)(31,367)(25,571)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 159127(93)(4)51(14)
Comprehensive loss, net of tax, attributable to parent:(45,741)(44,605)(49,264)(35,685)(36,295)(31,316)(25,585)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: